Reversible Posterior Leukoencephalopathy Syndrome During Regorafenib Treatment: A Case Report and Literature Review of Reversible Posterior Leukoencephalopathy Syndrome Associated With Multikinase Inhibitors-Reference-Cited by-同舟云学术

Reversible Posterior Leukoencephalopathy Syndrome During Regorafenib Treatment: A Case Report and Literature Review of Reversible Posterior Leukoencephalopathy Syndrome Associated With Multikinase Inhibitors

Published:2014-06 Issue:2 Volume:13 Page:127-130
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Myint Zaw W.,Sen Jeremy M.,Watts Nicole L.,Druzgal Thomas J.,Nathan Barnett R.,Ward Melanie D.,Boyer James E.,Fracasso Paula M.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference25 articles.

1. A reversible posterior leukoencephalopathy syndrome;Hinchey;N Engl J Med,1996

2. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings;Fugate;Mayo Clin Proc,2010

3. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents;Tlemsani;Target Oncol,2011

4. Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation;Barbas;Am J Transplant,2013

5. Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide;Chow;Leuk Lymphoma,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status;Medical Oncology;2023-12-21

2. Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review;Frontiers in Pharmacology;2023-12-15

3. Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report;International Journal of Endocrinology and Metabolism;2023-07-29

4. Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review;Frontiers in Pharmacology;2023-02-06

5. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma;Brain Sciences;2022-12-23